Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Lifetime breast cancer risk associated with BRCA 1 and BRCA 2 mutations among patients of Ashkenazi Jewish origin
    Meeting Abstract

    Begg, C. B.; Satagopan, J. M.; Robson, M.; Offit, K.
    American Journal of Human Genetics (1999)

    Fulltext@MSK | Save
  • Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer
    Journal Article

    Baselga, J.; Tripathy, D.; Mendelsohn, J.; Baughman, S.; Benz, C. C.; Dantis, L.; Sklarin, N. T.; Seidman, A. D.; Hudis, C. A.; Moore, J.; more...
    Seminars in Oncology (1999)

    Fulltext@MSK | Save
  • Phase I study of escalating doses of edatrexate in combination with paclitaxel in patients with metastatic breast cancer
    Journal Article

    D'Andrea, G.; Fennelly, D.; Norton, L.; Baselga, J.; Gilewski, T.; Hudis, C.; Moynahan, M. E.; Raptis, G.; Sklarin, N.; Surbone, A.; more...
    Clinical Cancer Research (1999)

    Fulltext@MSK | Save
  • The current state of adjuvant therapy for breast cancer: Focus on paclitaxel
    Journal Article

    Hudis, C. A.
    Seminars in Oncology (1999)

    Fulltext@MSK | Save
  • Kinetic concepts in the systemic drug therapy of breast cancer
    Journal Article

    Norton, L.
    Seminars in Oncology (1999)

    Fulltext@MSK | Save
  • Homologous recombination between heterologs during repair of a double-strand break: Suppression of translocations in normal cells
    Conference Paper

    Richardson, C.; Moynahan, M. E.; Jasin, M.
    John Wiley & Sons (1999)

    Fulltext@MSK | Save
  • Polysulfated heparinoids selectively inactivate heparin-binding angiogenesis factors
    Conference Paper

    Zugmaier, G.; Favoni, R.; Jaeger, R.; Rosen, N.; Knabbe, C.
    John Wiley & Sons (1999)

    Fulltext@MSK | Save
  • High-dose therapy for breast cancer
    Journal Article

    Hudis, C. A.; Munster, P. N.
    Seminars in Oncology (1999)

    Fulltext@MSK | Save
  • Update on the management of advanced breast cancer
    Journal Article

    Fornier, M.; Munster, P.; Seidman, A. D.; Winer, E. P.; Matulonis, U.; Blum, J. L.
    Oncology (Norwalk) (1999)

    Fulltext@MSK | Save
  • Adjuvant therapy for resectable breast cancer
    Journal Article

    Munster, P. N.; Hudis, C. A.
    Hematology/Oncology Clinics of North America (1999)

    Fulltext@MSK | Save